Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_assertion type Assertion NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_head.
- NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_assertion description "[We further showed that inferior OS and DSS were most pronounced in patients whose lymphomas contained both TNFRSF14 mutations and 1p36 deletions after adjustment for the International Prognostic Index [hazard ratios of 3.65 (95% confidence interval, 1.35-9.878, P=0.011) and 3.19 (95% confidence interval, 1.06-9.57, P=0.039), respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_provenance.
- NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_assertion evidence source_evidence_literature NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_provenance.
- NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_assertion SIO_000772 20884631 NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_provenance.
- NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_assertion wasDerivedFrom befree-20140225 NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_provenance.
- NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_assertion wasGeneratedBy ECO_0000203 NP623555.RAjYgpEosMP5PNuKHEXLhYOGFF4rhRi0Y7GQitiuW7Ggw130_provenance.